Citation Impact
Citing Papers
New approaches and procedures for cancer treatment: Current perspectives
2021 Standout
Peripheral Blood Progenitor Cell Transplantation: Clinical, Practical, and Economic Considerations
1994
Nosocomial Invasive Aspergillosis in Lymphoma Patients Treated with Bone Marrow or Peripheral Stem Cell Transplants
1993
The ISHAGE Guidelines for CD34+ Cell Determination by Flow Cytometry
1996 Standout
Etoposide: four decades of development of a topoisomerase II inhibitor
1998 Standout
Myeloid-derived suppressor cells coming of age
2018 Standout
Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
2013 Standout
Stem cells from bone marrow, umbilical cord blood and peripheral blood for clinical application: current status and future application
1996
Perspectives on cancer therapy-induced mucosal injury
2004 Standout
Platelet functions and clinical effects in acute myelogenous leukemia
2007
Acute leukaemia in bcr/abl transgenic mice
1990 Nature
Contribution of platelets to tumour metastasis
2011 Standout
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia
2002 Standout
Regimen-related toxicity and early posttransplant survival in patients undergoing marrow transplantation for lymphoma.
1989 StandoutNobel
A comparison of related donor peripheral blood and bone marrow transplants: Importance of late-onset chronic graft-versus-host disease and infections
2003
Acute graft-vs-host disease
2001
Autologous bone marrow transplantation in non-Hodgkin's lymphoma: monoclonal antibodies plus complement for ex Vivo marrow treatment
1988
Phenotypic conversion of T lymphoblastic lymphoma to acute biphenotypic leukemia composed of lymphoblasts and myeloblasts. Molecular genetic evidence of the same clonal origin.
1988 StandoutNobel
Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia
2001 Standout
Co‐stimulatory pathways in lymphocyte regulation: the immunoglobulin superfamily
2005 StandoutNobel
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
2014 Standout
Mesenchymal Stem Cell-Mediated Immunosuppression Occurs via Concerted Action of Chemokines and Nitric Oxide
2008 Standout
Regeneration of erythropoiesis after related‐ and unrelated‐donor BMT or peripheral blood HPC transplantation: a major ABO mismatch means problems
2000
Outcomes after major or bidirectional ABO‐mismatched allogeneic hematopoietic progenitor cell transplantation after pretransplant isoagglutinin reduction with donor‐type secretor plasma with or without plasma exchange
2011
Non‐endocrine late complications of bone marrow transplantation in childhood: part II
2002
Comparison of idarubicin to daunomycin in a randomized multidrug treatment of childhood acute lymphoblastic leukemia at first bone marrow relapse: A report from the Children's Cancer Group
1996
Mobilization and collection of peripheral blood progenitor cells for transplantation
2005
Chronic graft-versus-host disease
2003 Standout
High-dose cytarabine and total body irradiation with or without cyclophosphamide as a preparative regimen for marrow transplantation for acute leukemia.
1988
Effects of herbimycin A and its derivatives on growth and differentiation of Ph1-positive acute lymphoid leukemia cell lines
1994 StandoutNobel
Therapeutic apheresis in hematological and oncological diseases
2000
Graft-versus-host disease
2009 Standout
Pure Red Cell Aplasia After ABO Major‐Mismatched Allogeneic Peripheral Blood Stem Cell Transplantation Successfully Treated with Plasma Exchange and Low‐Dose Steroid: Two Case Reports
2004
Peripheral blood stem cell donation: an analysis from the International Bone Marrow Transplant Registry (IBMTR) and European Group for Blood and Marrow Transplant (EBMT) databases
2001
Hematopoietic Stem-Cell Transplantation
2006 Standout
Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
2004 Standout
Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study
2008 Standout
Transplantation of Anergic Histoincompatible Bone Marrow Allografts
1999
Defining the Intensity of Conditioning Regimens: Working Definitions
2009 Standout
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
2020 Standout
Treatment of pure red-cell aplasia following major ABO-mismatched T-cell-depleted bone marrow transplantation
1991
Bone Marrow Transplantation for Treatment of Leukemia in Children
1988
A Comparison of Cyclophosphamide and Total Body Irradiation with Etoposide and Total Body Irradiation as Conditioning Regimens for Patients Undergoing Sibling Allografting for Acute Lymphoblastic Leukemia in First or Second Complete Remission
2006
Unique fusion of bcr and c-abl genes in Philadelphia chromosome positive acute lymphoblastic leukemia
1987
Resistant pure red cell aplasia after allogeneic stem cell transplantation with major ABO mismatch treated by escalating dose donor leukocyte infusion
2004
The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
2016 Standout
Bone Marrow Transplantation in the Treatment of Children with Cancer: Current Status
1987
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Hyperacute graft-v-host disease in patients not given immunosuppression after allogeneic marrow transplantation
1986
Peripheral blood stem cell transplants for multiple myeloma: identification of favorable variables for rapid engraftment in 225 patients
1995
The Role of Cytotoxic Therapy with Hematopoietic Stem Cell Transplantation in the Therapy of Acute Myeloid Leukemia in Children: An Evidence-Based Review
2007
The processing of stem cell concentrates from the bone marrow in ABO-incompatible transplants: how and when.
2014
Acute and chronic graft-versus-host disease in man
1986
ICRP PUBLICATION 118: ICRP Statement on Tissue Reactions and Early and Late Effects of Radiation in Normal Tissues and Organs — Threshold Doses for Tissue Reactions in a Radiation Protection Context
2012 Standout
Bone Marrow Transplants from HLA-Identical Siblings as Compared with Chemotherapy for Children with Acute Lymphoblastic Leukemia in a Second Remission
1994
Peripheral blood stem cell versus bone marrow allotransplantation: does the source of hematopoietic stem cells matter?
2001
Current and Emerging Azole Antifungal Agents
1999 Standout
Antifungal prophylaxis during neutropenia and immunodeficiency
1997
Lectins: Carbohydrate-Specific Proteins That Mediate Cellular Recognition
1998 Standout
Graft-versus-leukemia reactions after bone marrow transplantation
1990 Standout
Second neoplasms in acute lymphoblastic leukemia
1983
The Absolute Number of Peripheral Blood CD34+ Cells Predicts a Timing for Apheresis and Progenitor Cell Yield in Patients with Hematologic Malignancies and Solid Tumors
2003 StandoutNobel
Guidelines for environmental infection control in health-care facilities. Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC).
2003 Standout
Graft‐versus‐Host Disease in Dog and Man: The Seattle Experience
1985 StandoutNobel
Successful engraftment of T-cell-depleted haploidentical "three-loci" incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum
1994
Prophylactic red blood cell exchange for ABO ‐mismatched hematopoietic progenitor cell transplants
2013
No difference in graft-versus-host disease, relapse, and survival comparing peripheral stem cells to bone marrow using unrelated donors
2001
2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings
2007 Standout
Complexity and challenges in defining myeloid-derived suppressor cells
2014
Titers of Antibody to Pneumococci in Allogeneic Bone Marrow Transplant Recipients Before and After Vaccination with Pneumococcal Vaccine
1986
Marrow transplantation for acute lymphoblastic leukemia: factors affecting relapse and survival
1989
Aspergillus fumigatusand Aspergillosis
1999 Standout
Granulocyte Colony-Stimulating Factor Reduces the Capacity of Blood Mononuclear Cells to Induce Graft-Versus-Host Disease: Impact on Blood Progenitor Cell Transplantation
1997
Bone Marrow Transplant
1990 Standout
Delayed donor red cell chimerism and pure red cell aplasia following major ABO-incompatible nonmyeloablative hematopoietic stem cell transplantation
2001
Treatment of pure red-cell aplasia following major ABO-mismatched T-cell-depleted bone marrow transplantation: Two case reports with successful response to plasmapheresis
1991
Prevention of pure red cell aplasia after major or bidirectional ABO blood group incompatible hematopoietic stem cell transplantation by pretransplant reduction of host anti-donor isoagglutinins
2009
Guidelines for Preventing Health-Care-Associated Pneumonia, 2003: Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee
2004 Standout
In vivo hematopoietic stem cell modification by mRNA delivery
2023 StandoutScienceNobel
Effectiveness of Donor Natural Killer Cell Alloreactivity in Mismatched Hematopoietic Transplants
2002 StandoutScience
Harvesting and enrichment of hematopoietic progenitor cells mobilized into the peripheral blood of normal donors by granulocyte-macrophage colony-stimulating factor (GM-CSF) or G-CSF: potential role in allogeneic marrow transplantation
1995
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
Risk assessment in haematopoietic stem cell transplantation: Conditioning
2007
Photopharmacology: Beyond Proof of Principle
2014 StandoutNobel
Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT).
2000
Hemolysis of transfused group O red blood cells in minor ABO- incompatible unrelated-donor bone marrow transplants in patients receiving cyclosporine without posttransplant methotrexate
1992
Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor [see comments]
1995
Cytokine-induced radiation protection and sensitization
1996
Works of PI Warkentin being referenced
Allogeneic-blood stem-cell collection following mobilization with low-dose granulocyte colony-stimulating factor.
1997
Comparison of monocyte-dependent T cell inhibitory activity in GM-CSF vs G-CSF mobilized PSC products
1998
Hemotherapy in patients undergoing blood group incompatible bone marrow transplantation
1983
Incidence of acute graft-versus-host disease with and without methotrexate prophylaxis in allogeneic bone marrow transplant patients
1984
Bone marrow transplantation for peripheral T-cell lymphoma in children and adolescents
1992
High-dose cytosine arabinoside and fractionated total-body irradiation: an improved preparative regimen for bone marrow transplantation of children with acute lymphoblastic leukemia in remission
1988
Oropharyngeal Candida prophylaxis in pediatric bone marrow transplant patients.
1985
Philadelphia chromosome positive childhood acute lymphoblastic leukemia
1980
High-dose therapy and peripheral blood progenitor cell transplantation: effects of recombinant human granulocyte-macrophage colony-stimulating factor on the autograft
1994
High-dose therapy and peripheral blood progenitor cell transplantation: effects of recombinant human granulocyte-macrophage colony-stimulating factor on the autograft
1994
Allogeneic bone marrow transplantation for children with acute leukemia: long-term follow-up of patients prepared with high-dose cytosine arabinoside and fractionated total body irradiation
1997
Bone marrow transplantation for acute leukemia and lymphoma with high-dose cytosine arabinoside and total body irradiation.
1985
Allogeneic transplantation of blood-derived, T cell-depleted hemopoietic stem cells after myeloablative treatment in a patient with acute lymphoblastic leukemia.
1989